Myrexis, Inc. (MYRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0070
0.00 (0.00%)
At close: Jan 17, 2025
Myrexis Statistics
Total Valuation
Myrexis has a market cap or net worth of 241,353.
Market Cap | 241,353 |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Myrexis has 34.48 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 34.48M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +15.27% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.21 |
P/TBV Ratio | 0.21 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.72
Current Ratio | 16.72 |
Quick Ratio | 16.35 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.67% and return on invested capital (ROIC) is -15.45%.
Return on Equity (ROE) | -25.67% |
Return on Assets (ROA) | -15.06% |
Return on Capital (ROIC) | -15.45% |
Revenue Per Employee | n/a |
Profits Per Employee | -11.62M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.67% in the last 52 weeks. The beta is 1.47, so Myrexis's price volatility has been higher than the market average.
Beta (5Y) | 1.47 |
52-Week Price Change | -6.67% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.01 |
Relative Strength Index (RSI) | 46.66 |
Average Volume (20 Days) | 9,514 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.19 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -11.19M |
Pretax Income | -11.62M |
Net Income | -11.62M |
EBITDA | -10.81M |
EBIT | -11.19M |
Earnings Per Share (EPS) | -0.39 |
Balance Sheet
Cash & Cash Equivalents | 1.21M |
Total Debt | n/a |
Net Cash | 1.21M |
Net Cash Per Share | 0.04 |
Equity (Book Value) | 1.16M |
Book Value Per Share | 0.03 |
Working Capital | 1.16M |
Cash Flow
Operating Cash Flow | -12.97M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Myrexis does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.83% |
Shareholder Yield | -11.83% |
Earnings Yield | -4,814.94% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |